References
- Kim JH, Jenrow KA, Brown SL. Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials. Radiat Oncol J 2014; 32: 103-15. 10.3857/roj.2014.32.3.103
- Price RE, Langford LA, Jackson EF, Stephens LC, Tinkey PT, Ang KK. Radiation-induced morphologic changes in the rhesus monkey (Macaca mulatta) brain. J Med Primatol 2001; 30: 81-7. 10.1034/j.1600-0684.2001.300202.x
- Sundgren PC, Cao Y. Brain irradiation: effects on normal brain parenchyma and radiation injury. Neuroimaging Clin N Am 2009; 19: 657-68. 10.1016/j.nic.2009.08.014
- Greene-Schloesser D, Robbins ME, Peiffer AM, Shaw EG, Wheeler KT, Chan MD. Radiation-induced brain injury: a review. Front Oncol 2012; 2: 73. 10.3389/fonc.2012.00073
- Cao Y, Tsien CI, Sundgren PC, Nagesh V, Normolle D, Buchtel H, et al. Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for prediction of radiation-induced neurocognitive dysfunction. Clin Cancer Res 2009; 15: 1747-54. 10.1158/1078-0432.CCR-08-1420
- Adair JC, Baldwin N, Kornfeld M, Rosenberg GA. Radiation-induced blood-brain barrier damage in astrocytoma: relation to elevated gelatinase B and urokinase. J Neurooncol 1999; 44: 283-9.
- Fuss M, Wenz F, Scholdei R, Essig M, Debus J, Knopp MV, et al. Radiation-induced regional cerebral blood volume (rCBV) changes in normal brain and low-grade astrocytomas: quantification and time and dose-dependent occurrence. Int J Radiat Oncol Biol Phys 2000; 48: 53-8. 10.1016/S0360-3016(00)00590-3
- Jakubovic R, Sahgal A, Ruschin M, Pejovic-Milic A, Milwid R, Aviv RI. Non tumor perfusion changes following stereotactic Radiosurgery to brain metastases. Technol Cancer Res Treat 2014. 10.7785/tcrtex-press.2013.600279
- Lee MC, Cha S, Chang SM, Nelson SJ. Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases. J Magn Reson Imaging 2005; 21: 683-93. 10.1002/jmri.20298
- Petr J, Platzek I, Seidlitz A, Mutsaerts HJ, Hofheinz F, Schramm G, et al. Early and late effects of radiochemotherapy on cerebral blood flow in glioblastoma patients measured with non-invasive perfusion MRI. Radiother Oncol 2016; 118: 24-8. 10.1016/j.radonc.2015.12.017
- Price SJ, Jena R, Green HA, Kirkby NF, Lynch AG, Coles CE, et al. Early radiotherapy dose response and lack of hypersensitivity effect in normal brain tissue: a sequential dynamic susceptibility imaging study of cerebral perfusion. Clin Oncol (R Coll Radiol) 2007; 19: 577-87. 10.1016/j.clon.2007.04.010
- Taki S, Higashi K, Oguchi M, Tamamura H, Tsuji S, Ohta K, et al. Changes in regional cerebral blood flow in irradiated regions and normal brain after stereotactic radiosurgery. Ann Nucl Med 2002; 16: 273-7.
- Weber MA, Gunther M, Lichy MP, Delorme S, Bongers A, Thilmann C, et al. Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue. Invest Radiol 2003; 38: 712-8. 10.1097/01.rli.0000084890.57197.54
- Wenz F, Rempp K, Hess T, Debus J, Brix G, Engenhart R, et al. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 1996; 166: 187-93. 10.2214/ajr.166.1.8571873
- Paulson ES, Schmainda KM. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008; 249: 601-13. 10.1148/radiol.2492071659
- Jafari-Khouzani K, Emblem KE, Kalpathy-Cramer J, Bjornerud A, Vangel MG, Gerstner ER, et al.Repeatability of cerebral perfusion using dynamic susceptibility contrast MRI in glioblastoma patients. Transl Oncol 2015; 8: 137-46. 10.1016/j.tranon.2015.03.002
- Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008; 247: 490-8. 10.1148/radiol.2472070898
- Lacerda S, Law M. Magnetic resonance perfusion and permeability imaging in brain tumors. Neuroimaging Clin N Am 2009; 19: 527-57. 10.1016/j.nic.2009.08.007
- Jarnum H, Steffensen EG, Knutsson L, Frund ET, Simonsen CW, Lundbye-Christensen S, et al. Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging. Neuroradiology 2010; 52: 307-17. 10.1007/s00234-009-0616-6
- Choi SH, Jung SC, Kim KW, Lee JY, Choi Y, Park SH, et al. Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis. J Neurooncol 2016; 128: 185-94. 10.1007/s11060-016-2102-4
- Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, et al. Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery 2012; 70: 234-43; discussion 43-4. 10.1227/NEU.0b013e318223f5a7
- Tensaouti F, Khalifa J, Lusque A, Plas B, Lotterie JA, Berry I, et al. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma. Neuroradiology 2017; 59: 1013-20. 10.1007/s00234-017-1899-7
- Bjornerud A, Emblem KE. A fully automated method for quantitative cerebral hemodynamic analysis using DSC-MRI. J Cereb Blood Flow Metab 2010; 30: 1066-78. Epub 2010/01/21. 10.1038/jcbfm.2010.4
- Knutsson L, Stahlberg F, Wirestam R. Absolute quantification of perfusion using dynamic susceptibility contrast MRI: pitfalls and possibilities. MAGMA 2010; 23: 1-21. 10.1007/s10334-009-0190-2
- Mouridsen K, Christensen S, Gyldensted L, Ostergaard L. Automatic selection of arterial input function using cluster analysis. Magn Reson Med 2006; 55: 524-31. 10.1002/mrm.20759
- Petersen ET, Zimine I, Ho YC, Golay X. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br J Radiol 2006; 79: 688-701. 10.1259/bjr/67705974
- Emblem KE, Bjornerud A. An automatic procedure for normalization of cerebral blood volume maps in dynamic susceptibility contrast-based glioma imaging. AJNR Am J Neuroradiol 2009; 30: 1929-32. 10.3174/ajnr.A1680
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-96. 10.1056/NEJMoa043330
- Ostergaard L. Principles of cerebral perfusion imaging by bolus tracking. J Magn Reson Imaging 2005; 22: 710-7. 10.1002/jmri.20460
- Simonsen CZ, Ostergaard L, Vestergaard-Poulsen P, Rohl L, Bjornerud A, Gyldensted C. CBF and CBV measurements by USPIO bolus tracking: reproducibility and comparison with Gd-based values. J Magn Reson Imaging 1999; 9: 342-7. 10.1002/(SICI)1522-2586(199902)9:2<;342::AID-JMRI29>3.0.CO;2-B
- Emblem KE, Bjornerud A, Mouridsen K, Borra RJ, Batchelor TT, Jain RK, et al. T(1)- and T(2)(∗)-dominant extravasation correction in DSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients. J Cereb Blood Flow Metab 2011; 31: 2054-64. 10.1038/jcbfm.2011.39
- Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magn Reson Med 1996; 36: 726-36. 10.1002/mrm.1910360511
- Calamante F, Gadian DG, Connelly A. Quantification of bolus-tracking MRI: improved characterization of the tissue residue function using Tikhonov regularization. Magn Reson Med 2003; 50: 1237-47. 10.1002/mrm.10643
- Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006; 27: 859-67.
- Emblem KE, Due-Tonnessen P, Hald JK, Bjornerud A. Automatic vessel removal in gliomas from dynamic susceptibility contrast imaging. Magn Reson Med 2009; 61: 1210-7. 10.1002/mrm.21944
- Klein S, Staring M, Murphy K, Viergever MA, Pluim JP. Elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 2010; 29: 196-205. 10.1109/TMI.2009.2035616
- White CM, Pope WB, Zaw T, Qiao J, Naeini KM, Lai A, et al. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors. J Neuroimaging 2014; 24: 23-30. 10.1111/j.1552-6569.2012.00703.x
- Jonsson C, Pagani M, Johansson L, Thurfjell L, Jacobsson H, Larsson SA. Reproducibility and repeatability of 99Tcm-HMPAO rCBF SPET in normal subjects at rest using brain atlas matching. Nucl Med Commun 2000; 21: 9-18.
- Li YQ, Chen P, Haimovitz-Friedman A, Reilly RM, Wong CS. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. Cancer Res 2003; 63: 5950-6.
- Lyubimova N, Hopewell JW. Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury. Br J Radiol 2004; 77: 488-92. 10.1259/bjr/15169876
- Cao Y, Tsien CI, Shen Z, Tatro DS, Ten Haken R, Kessler ML, et al. Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy. J Clin Oncol 2005; 23: 4127-36. 10.1200/JCO.2005.07.144
- Brown WR, Thore CR, Moody DM, Robbins ME, Wheeler KT. Vascular damage after fractionated whole-brain irradiation in rats. Radiat Res 2005; 164: 662-8.
- Coderre JA, Morris GM, Micca PL, Hopewell JW, Verhagen I, Kleiboer BJ, et al. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiat Res 2006; 166: 495-503. 10.1667/RR3597.1
- Wong CS, Van der Kogel AJ. Mechanisms of radiation injury to the central nervous system: implications for neuroprotection. Mol Interv 2004; 4: 273-84. 10.1124/mi.4.5.7
- Yuan H, Gaber MW, Boyd K, Wilson CM, Kiani MF, Merchant TE. Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation, and ultrastructural changes. Int J Radiat Oncol Biol Phys 2006; 66: 860-6. 10.1016/j.ijrobp.2006.06.043
- Prust MJ, Jafari-Khouzani K, Kalpathy-Cramer J, Polaskova P, Batchelor TT, Gerstner ER, et al. Standard chemoradiation for glioblastoma results in progressive brain volume loss. Neurology 2015; 85: 683-91. 10.1212/WNL.0000000000001861
- Karunamuni RA, Moore KL, Seibert TM, Li N, White NS, Bartsch H, et al. Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging. Radiother Oncol 2016; 118: 29-34. 10.1016/j.radonc.2016.01.003
- Petr J, Platzek I, Hofheinz F, Mutsaerts H, Asllani I, van Osch MJP, et al. Photon vs. proton radiochemotherapy: effects on brain tissue volume and perfusion. Radiother Oncol 2018. 10.1016/j.radonc.2017.11.033
- Karunamuni R, Bartsch H, White NS, Moiseenko V, Carmona R, Marshall DC, et al. Dose-dependent cortical thinning after partial brain irradiation in highgrade glioma. Int J Radiat Oncol Biol Phys 2016; 94: 297-304. 10.1016/j.ijrobp.2015.10.026
- Andre JB, Nagpal S, Hippe DS, Ravanpay AC, Schmiedeskamp H, Bammer R, et al. Cerebral blood flow changes in glioblastoma patients undergoing bevacizumab treatment are seen in both tumor and normal brain. [Abstract] Neuroradiol J 2015; 28: 112-9. 10.1177/1971400915576641
- Mouridsen K, Emblem K, Bjørnerud A, Jennings D, Sorensen AG. Subject-specific AIF optimizes reproducibility of perfusion parameters in longitudinal DSC-MRI. Proc Intl Soc Mag Reson Med 2011; 19: 376.